PharmaShots | Incisive News in 3 Shots

Subscribe Now

Puma Biotechnology

PharmaShots Weekly Snapshots (March 13 - 17, 2023)

PharmaShots Weekly Snapshots (March 13 - 17, 2023)

March 17, 2023

Puma Biotechnology Publishes P-II Trial (TBCRC041) Results of Alisertib for Endocrine-Resistant Advanced Breast Cancer in JAMA Oncology

Puma Biotechnology Publishes P-II Trial (TBCRC041) Results of Alisertib for Endocrine-Resistant Advanced Breast Cancer in JAMA Onc...

March 15, 2023

PharmaShots' Most Read News of 2022

PharmaShots' Most Read News of 2022

January 2, 2023

PharmaShots Weekly Snapshots (September 19 - 23, 2022)

PharmaShots Weekly Snapshots (September 19 - 23, 2022)

September 23, 2022

Takeda Entered into an Exclusive License Agreement with Puma Biotechnology for the Development and Commercialization of Alisertib

Takeda Entered into an Exclusive License Agreement with Puma Biotechnology for the Development and Commercialization of Alisertib

September 21, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us